Skip to main content
. 2021 Jun 17;17(12):e1895–e1904. doi: 10.1200/OP.20.01082

FIG 1.

FIG 1.

Patterns over time of OAA initiation within 12 months of year of index metastatic RCC diagnosis, with FDA approval dates noted. FDA, US Food and Drug Administration; OAA, oral anticancer agent; RCC, renal cell carcinoma.